Delafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Public ClinicalTrials.gov record NCT01984684. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multicenter, Randomized, Double-blind, Active Controlled Study to Evaluate the Efficacy + Safety of IV + Oral Delafloxacin Compared With Vancomycin + Aztreonam in Patients With Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the effects of Delafloxacin versus Vancomycin plus Aztreonam in the treatment of patients with acute bacterial skin and soft tissue infections.
Study identification
- NCT ID
- NCT01984684
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 850 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2014 (Actual)
- Primary completion
- Dec 2015 (Actual)
- Completion
- Jan 2016 (Actual)
- Last update posted
- Nov 17, 2017
2014 – 2016
United States locations
- U.S. sites
- 31
- U.S. states
- 15
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Melinta 303 Study Site | Mobile | Alabama | 36607 | — |
| Melinta 303 Study Site | Montgomery | Alabama | — | — |
| Melinta 303 Study Site | Anaheim | California | — | — |
| Melinta 303 Study Site | Chula Vista | California | 91911 | — |
| Melinta 303 Study Site | La Mesa | California | 91942 | — |
| Melinta 303 Study Site | Long Beach | California | — | — |
| Melinta 303 Study Site | Modesto | California | — | — |
| Melinta 303 Study Site | Oceanside | California | 92056 | — |
| Melinta 303 Study Site | San Diego | California | 92114 | — |
| Melinta 303 Study Site | Stockton | California | — | — |
| Melinta 303 Study Site | Torrance | California | 90509 | — |
| Melinta 303 Study Site | DeLand | Florida | — | — |
| Melinta 303 Study Site | Orlando | Florida | — | — |
| Melinta 303 Study Site | Columbus | Georgia | 31904 | — |
| Melinta 303 Study Site | Savannah | Georgia | 31405 | — |
| Melinta 303 Study Site | Eunice | Louisiana | 70535 | — |
| Melinta 303 Study Site | Springfield | Massachusetts | — | — |
| Melinta 303 Study Site | Minneapolis | Minnesota | 55422 | — |
| Melinta 303 Study Site | Butte | Montana | — | — |
| Melinta 303 Study Site | Lincoln | Nebraska | — | — |
| Melinta 303 Study Site | Las Vegas | Nevada | 89109 | — |
| Melinta 303 Study Site | Somers Point | New Jersey | 08244 | — |
| Melinta 303 Study Site | Teaneck | New Jersey | — | — |
| Melinta 303 Study Site | Columbus | Ohio | — | — |
| Melinta 303 Study Site | Toledo | Ohio | — | — |
| Melinta 303 Study Site | Rapid City | South Dakota | — | — |
| Melinta 303 Study Site | Jackson | Tennessee | — | — |
| Melinta 303 Study Site | Smyrna | Tennessee | — | — |
| Melinta 303 Study Site | Channelview | Texas | 77530 | — |
| Melinta 303 Study Site | Houston | Texas | 77024 | — |
| Melinta 303 Study Site | San Antonio | Texas | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 63 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01984684, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 17, 2017 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01984684 live on ClinicalTrials.gov.